Go AS, Hylek EM,
Phillips
KA, et al. Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management and stroke
prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)
Study. JAMA . 2001;
285:2370-2375.
2.
Miyasaka Y., Barnes ME,
Gersh
BJ, et al. Secular trends in incidence of
atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the
projections for future prevalence. Circulation.
2006;114:119-125.
3.
Naccarelli GV , Varker H.,
Lin
J., Schulman KLIncreasing
prevalence of atrial fibrillation and atrial flutter in the United
States. Am J Cardiol.
2009;104:1534-1539.
4.
Stewart S., Hart CL,
Hole
DJ, McMurray JJA
population-based study of the long-term risks associated with atrial fibrillation:
20-year follow-up of the Renfrew/Paisley study. Am J
Med.
2002;113:359-364.
5.
Friberg J., Buch P.,
Scharling
H., Gadsbphioll N., Jensen
GBRising rates of hospital admissions for
atrial fibrillation. Epidemiology.
2003;14:666-672.
6.
Hohnloser SH , Crijns HJ,
van Eickels
M., et al. Effect of dronedarone on
cardiovascular events in atrial fibrillation. N Engl J
Med. 2009;
360:668-678.
